Indian Stock Market Today:Indian equity markets opened cautiously on May 27 as investors balanced strong corporate earnings, sector-specific rallies and global geopolitical uncertainty.

GIFT Nifty futures indicated a muted start, trading 88 points lower at 23,890 while Asian markets remained largely positive amid optimism surrounding a fragile ceasefire between the United States and Iran. Back home, sectors including realty, capital goods, energy, railways and pharmaceuticals remained active as several companies posted quarterly earnings, hit 52-week highs or announced strategic developments likely to shape investor sentiment in the coming weeks.

Stock To Watch Today (May 27, 2026)

Oil & Natural Gas Corporation (ONGC)

State-run Oil and Natural Gas Corporation reported a 3% rise in Q4FY26 net profit at ₹6,649.97 crore compared with ₹6,448.28 crore a year ago with higher crude and gas prices supported profitability despite softer production numbers. The energy major remains central to India's domestic energy security strategy, especially as oil prices continue reacting to instability in the Middle East.

Indian Railway Catering and Tourism Corporation (IRCTC)

Indian Railway Catering and Tourism Corporation posted mixed quarterly numbers and net profit fell 9% year-on-year to ₹326 crore, while revenue climbed 15.1% to ₹1,460 crore. The company also announced a final dividend of ₹0.50 per share while analysts believe strong travel demand and railway modernization could continue supporting long-term revenue growth despite short-term pressure on margins.

Coal India

Coal India remained in focus after the government announced plans to divest up to a 2% stake through an Offer for Sale (OFS). The floor price was fixed at ₹412 per share while the move is expected to strengthen government disinvestment targets while testing investor appetite for public sector energy stocks.

Hindalco Industries

Hindalco Industries touched a fresh 52-week high of ₹1,152 during intraday trade while rising global metal demand, infrastructure spending and improving industrial activity helped support buying momentum in metal stocks. Market participants also expect continued growth in aluminium demand from electric vehicles and renewable energy projects.

Adani Energy

Adani Energy Solutions climbed to a new 52-week high near ₹1,516.7 while investors remain optimistic about transmission expansion, renewable energy investments and infrastructure spending across India. Broader Adani Group companies also witnessed renewed investor interest amid improving market sentiment.

AstraZeneca Pharma

AstraZeneca Pharma India reported a 20.4% jump in revenue to ₹578.6 crore, though profitability weakened sharply. Net profit dropped 23% to ₹44.8 crore, while EBITDA margins narrowed to 10.5% from 17.9% a year earlier and the company nevertheless announced a final dividend of ₹36 per share.

JK Tyre & Industries

JK Tyre & Industries posted a strong earnings recovery, with Q4 consolidated net profit nearly doubling to ₹178 crore. Revenue rose 12.4% to ₹4,223 crore, supported by improving automobile demand and stronger replacement tyre sales across domestic and export markets.

Siemens

Siemens remained among the top gainers in the capital goods space despite reporting a 36.4% fall in quarterly profit. Revenue increased 14.6% to ₹4,617.5 crore, reflecting continued industrial and infrastructure demand in India while investors largely focused on future order books and capital expenditure opportunities.

Senco Gold

Senco Gold delivered one of the strongest Q4 performances in the retail segment while revenue surged to ₹1,997 crore from ₹1,378 crore, while profit after tax jumped 2.5 times to ₹157 crore. The company also recorded its highest-ever fourth-quarter retail sales at ₹1,731 crore, up 35% year-on-year.

Sun Pharma

Sun Pharmaceutical Industries announced updated trial data for its cancer treatment drug Unloxcyt at the ASCO Annual Meeting in Chicago. The data showed durable patient responses and manageable safety outcomes in advanced skin cancer treatment, reinforcing Sun Pharma's growing focus on specialty healthcare and oncology research.